印度与Vericiguat的经验:基于案例系列的审查
Upendra Kaul1, Jamshed Dalal2, Jagdish Hiremath3
1Batra Hospital and Medical Research Centre, Delhi, India, Corresponding Author.
The Journal of the Association of Physicians of India
|October 11, 2024
概括
维里西瓜特是一种针对心力衰竭 (HF) 的新疗法,有望减少因心力衰竭 (WHF) 恶化的住院病例. 早期启动可能会使特定高风险患者群体受益.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 心力衰竭 (HF) 经常导致住院和疾病进展.
- 目前对HF的治疗旨在减少心血管事件,但残留风险仍然存在.
- 心力衰竭 (WHF) 的恶化意味着一个关键阶段,需要优化治疗策略.
研究的目的:
- 为了探索早期的输血管启动在患有WHF的患者的潜在好处.
- 为了识别那些可能从早期输血管治疗中获益最多的特定患者概况.
- 评估 vericiguat作为一个有前途的治疗选择来管理WHF.
主要方法:
- 这篇文章回顾了早期输送器启动的潜在好处.
- 这项研究侧重于四种不同的WHF患者个人资料.
- 分析是基于现有的数据和临床理解 vericiguat的机制.
主要成果:
- 维瑞西瓜特是一种可溶性瓜尼酸环酶 (sGC) 刺激剂,是一种新的治疗剂.
- 早期启动 vericiguat可能在特定患者队列中提供优势.
- 该药物为患有恶化心力衰竭迹象的患者提供了一个有前途的选择.
结论:
- 维里西瓜特代表了管理心力衰竭与恶化的症状的潜在进步.
- 早期干预的 vericiguat 可能是一个有价值的战略,为选择HF患者.
- 需要对WHF的早期受体使用进行进一步的调查.
相关概念视频
01:19Pharmacovigilance
783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K